Home LiteratureArticle Details
PMID: 2769183 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin.

The Journal of experimental medicine ·Vol. 170 ·No. 3 ·1989-09-01 ·Pages 913-31

Gerlach H, Lieberman H, Bach R, Godman G, Brett J, Stern D

Abstract

Some in vivo observations have suggested that growing or perturbed endothelium, such as that which occurs during angiogenesis, is more sensitive to the action of cytokines (TNF/cachectin, TNF, or IL-1) than normal quiescent endothelial cells. This led us to examine the responsiveness of endothelium to TNF as a function of the growth/motile state of the cell. TNF-induced modulation of endothelial cell surface coagulant function was half-maximal at a concentration of approximately 0.1 nM in subconfluent cultures, whereas 1-2 nM was required for the same effect in postconfluent cultures. Perturbation of endothelial cell shape/cytoskeleton was similarly more sensitive to TNF in subconfluent cultures. Consistent with these results, radioligand binding studies demonstrated high affinity TNF binding sites, Kd approximately 0.1 nM on subconfluent cultures, whereas only lower affinity sites (Kd approximately 1.8 nM) were detected on postconfluent cultures. The mechanisms underlying this change in the affinity of endothelium for TNF were studied in four settings. Crosslinking experiments with 125I-TNF and endothelium showed additional bands corresponding to Mr approximately 66,000 and approximately 84,000 with subconfluent cultures that were not observed with postconfluent cultures. Experiments with X-irradiated endothelium, whose growth but not motility was blocked, indicated that proliferation was not required for induction of high affinity TNF sites. Postconfluent endothelium, triggered to enter the proliferative cycle by microbutuble poisons, expressed high affinity TNF binding sites together with changes in cell shape/cytoskeleton well before their entry into S phase. Using wounded postconfluent monolayers, cells that migrated into the wound and those close to the wound edge displayed enhanced TNF binding and modulation of coagulant properties. These results suggest a model for targetting TNF action within the vasculature; regulation of high affinity endothelial cell binding sites can direct TNF to activated cells in particular parts of the vascular tree.

MeSH Terms
Animals Binding Sites Cattle Cell Division Cell Movement Cells, Cultured Cytoskeleton/metabolism Endothelium, Vascular/drug effects,physiology Molecular Weight Tumor Necrosis Factor-alpha/metabolism,pharmacology
Chemicals
Tumor Necrosis Factor-alpha
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Gerlach H
Department of Physiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
Lieberman H
Bach R
Godman G
Brett J
Stern D
References (39)
39 references, click to expand
  1. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture.
    Thromb Res. 1985 Dec 1;40(5):677-91 PMID: 4089833
  2. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.
    J Exp Med. 1989 Jun 1;169(6):1977-91 PMID: 2499653
  3. Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
    J Exp Med. 1986 Mar 1;163(3):740-5 PMID: 3753996
  4. Participation of endothelial cells in the protein C-protein S anticoagulant pathway: the synthesis and release of protein S.
    J Cell Biol. 1986 May;102(5):1971-8 PMID: 2939094
  5. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1363-75 PMID: 3011946
  6. The effect of bovine thrombomodulin on the specificity of bovine thrombin.
    J Biol Chem. 1986 Mar 15;261(8):3876-82 PMID: 3005304
  7. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  8. Synthesis of antihemophilic factor antigen by cultured human endothelial cells.
    J Clin Invest. 1973 Nov;52(11):2757-64 PMID: 4583980
  9. Immunization, isolation of immunoglobulins, estimation of antibody titre.
    Scand J Immunol Suppl. 1973;1:161-4 PMID: 4204108
  10. Protein iodination with solid state lactoperoxidase.
    Biochemistry. 1974 Feb 26;13(5):1014-21 PMID: 4360349
  11. Radiosensitivity of human endothelial cells in culture.
    J Lab Clin Med. 1974 Jul;84(1):42-8 PMID: 4833841
  12. Role of cell shape in growth control.
    Nature. 1978 Jun 1;273(5661):345-9 PMID: 661946
  13. Selection and characterization of bovine aortic endothelial cells.
    In Vitro. 1978 Dec;14(12):966-80 PMID: 570168
  14. The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.
    Biochim Biophys Acta. 1979 Dec 7;571(2):333-42 PMID: 508770
  15. Purification and characterization of bovine tissue factor.
    J Biol Chem. 1981 Aug 25;256(16):8324-31 PMID: 6790539
  16. Effects of cytoskeletal disrupting agents on replication of bovine endothelium.
    J Cell Physiol. 1981 Aug;108(2):195-211 PMID: 7263771
  17. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen).
    Anal Biochem. 1981 Oct;117(1):136-46 PMID: 7316186
  18. In vitro reendothelialization. Microfilament bundle reorganization in migrating porcine endothelial cells.
    Arteriosclerosis. 1984 Mar-Apr;4(2):91-6 PMID: 6367729
  19. The role of membrane-membrane interactions in the regulation of endothelial cell growth.
    J Cell Biol. 1985 Jun;100(6):1934-40 PMID: 3997978
  20. Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.
    Proc Natl Acad Sci U S A. 1985 Sep;82(17):5756-60 PMID: 2994048
  21. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.
    Proc Natl Acad Sci U S A. 1986 Jun;83(12):4533-7 PMID: 3487091
  22. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines.
    Int J Cancer. 1986 Jul 15;38(1):127-33 PMID: 3087891
  23. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.
    J Biochem. 1986 Sep;100(3):531-41 PMID: 3023310
  24. Rapid modulation of tumor necrosis factor membrane receptors by activators of protein kinase C.
    Biochem Biophys Res Commun. 1986 Dec 15;141(2):855-60 PMID: 3026394
  25. The regulation of natural anticoagulant pathways.
    Science. 1987 Mar 13;235(4794):1348-52 PMID: 3029867
  26. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3293-7 PMID: 3033642
  27. The active form of tumor necrosis factor is a trimer.
    J Biol Chem. 1987 May 25;262(15):6951-4 PMID: 3034874
  28. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells.
    J Immunol. 1987 Aug 1;139(3):956-62 PMID: 3110292
  29. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.
    J Immunol. 1987 Aug 15;139(4):1161-7 PMID: 3038998
  30. The human interleukin-2 receptor: a molecular and biochemical analysis of structure and function.
    Clin Res. 1987 Sep;35(5):439-50 PMID: 2889557
  31. Endothelial cell procoagulant properties and the host response.
    Semin Thromb Hemost. 1987 Oct;13(4):391-7 PMID: 3321434
  32. Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells.
    Biochem J. 1988 Feb 15;250(1):125-32 PMID: 3128274
  33. Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration.
    Am J Pathol. 1988 Jul;132(1):18-27 PMID: 3394798
  34. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas.
    J Exp Med. 1988 Aug 1;168(2):637-47 PMID: 3411290
  35. Tumor necrosis factor and immune interferon act in concert to slow the lateral diffusion of proteins and lipids in human endothelial cell membranes.
    J Cell Biol. 1988 Aug;107(2):781-9 PMID: 3138247
  36. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.
    J Cell Biol. 1988 Oct;107(4):1269-77 PMID: 3049617
  37. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.
    Blood. 1989 Jan;73(1):159-65 PMID: 2535943
  38. Initiation of coagulation by tissue factor.
    CRC Crit Rev Biochem. 1988;23(4):339-68 PMID: 3067973
  39. Structure of tumour necrosis factor.
    Nature. 1989 Mar 16;338(6212):225-8 PMID: 2922050
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1989-09-01
Pages
913-31
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189421
Subset
IM
Grants
NCI NIH HHS · CA-43902 · United States
NHLBI NIH HHS · HL-34625 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]